Despite the progress achieved in pharmacotherapy, the symptoms remain to recover in a large proportion of people with depression, who undergo treatment with these drugs [17] . It is argued that antidepressants exert inhibitory effects and fail to treat the disease [18] . Therefore, it is necessary to find a useful therapeutic approach for the patients.
Using medicinal plants to treat mental disorders and chronic diseases has recently become widespread [19] [20] [21] . Lavandula officinalis is a medicinal plant that is used to treat depression. L. officinalis is a plant of family Lamiaceae [22] and has long been used as antibacterial, antifungal and antidepressant. L. officinalis oil is sedative and is used to treat wound burns and stings [22] . L. officinalis flower has therapeutic uses. L. officinalis contains flavonoid components that affect benzodiazepine receptors [23] . The existence of certain components, such as linalool and linalyl acetate and the flavonoid, such as luteolin in Lavandula Vera, raises the possibility that L. officinalis may be effective on central nervous system. The linalool in L. officinalis causes increase in noradrenalin and dopamine and therefore helps to exert antidepressant effect [24] . Inhaling the odour of linalool, a significant component of L. officinalis, has sedative effects on both humans and animals [25] .
The essential oil of L. officinalis contains monoterpenes (1-3%). The most important components are linalyl acetate (30%-55%), linalool (20%-35%), beta-ocimene, cineol, camphor, sesquiterpene, caryophyllene oxide, tannin, rosmarinic acid derivatives, coumarine and flavonoids [26] .
Antidepressants may not be welcomed because of inducing several side effects in some people [27] ; moreover, there are debates over the immunity and the side effects of the medicinal plants that are used to treat mental diseases [28] . Venlafaxine is a drug of choice to treat depression. To date, little research has been conducted on venlafaxine and no study has been conducted to compare the effects of venlafaxine with L. officinalis in depression. Therefore, it Materials and Methods: For this study, 120 patients referred to the psychiatry clinic of the Shahrekord University of Medical Sciences, Shahrekord, Iran, were randomly selected. The participants were randomly assigned to three groups:
officinalis Group), and venlafaxine + placebo (Placebo Group).
All the patients underwent treatment for six weeks. Depression test was administered to the three groups at different time intervals before the treatment, four weeks after the treatment and at completion of the treatment. The data were analysed by SPSS version17.0.
Results: Depression scores of all the groups decreased over time (p=0.001). The depression scores were significantly different between the control and L. officinalis groups (p=0.004), and the control and placebo groups (p=0.002), but were not significantly different between the L. officinalis and placebo groups (p=0.95).
Conclusion: Adding L. officinalis or a placebo is equally effective in decreasing mean depression score and venlafaxine obviously decreased this score.
indicated that the three groups were matched on age, gender, education level, and the place of residence (p>0.05) [Table/ Fig-1 ].
The depression scores of the groups were measured at the three points of time. The repeated measures ANOVA indicated that the depression indices of the groups decreased over time (p<0.001).
is necessary to find a useful therapeutic approach for the patients. This clinical trial was conducted to compare the therapeutic effects of venlafaxine and L. officinalis in people suffering from MDD.
MAtERIALS And MEthOdS
The study was a double-blind clinical trial and was conducted in 2015. The Ethics Committee of the Shahrekord University of Medical Sciences approved the protocol of the study (approval no. 25-94 and IRCT201604116480N13) . Study population consisted of the patients with mild to moderate MDD who were referred to the psychiatry clinic. The diagnosis was made by a structured clinical interview conducted by a psychiatrist according to the DSM-5 criteria [29, 30] . The patients with a score of at least 17 on Hamilton Depression Rating Scale were diagnosed with depression and included in the study.
Withdrawal from the study or being under routine treatments for depression, allergy to L. officinalis, history of using antidepressants, L. officinalis, or any medicinal plants with antidepressant effects, psychosis, underlying diseases and substance abuse were considered for exclusion. From the people with inclusion criteria who provided written consent to participate in the study, 120 people were selected. Sampling was done gradually and purposively. After the research purpose was explained to the people, they were assigned to three groups by simple randomization. For single blinding purpose we administered placebo to one of the study groups.
The patients were divided into three groups: Venlafaxine (Control Group), venlafaxine + L. officinalis (L. officinalis Group), and venlafaxine + placebo (Placebo Group). Control Group was administered with a routine treatment for depression, 37.5 mg venlafaxine, placebo group with 37.5 mg venlafaxine and peppermint (in a 1.5 gm tea bag placed in a cup of boiling water for 10-15 minutes and then taken with candy every 12 hours) (according to German pharmacopoeia), and case group with 37.5 g venlafaxine and L. officinalis (in a 1.5 g tea bag placed in a cup of boiling water for 10-15 minutes and then taken with candy every 12 hours) (according to German pharmacopoiea).
The enrollment of the people and administration of the treatments were conducted within six months. The questionnaire of depression was administered to all the patients prior to the treatments and then at three and six weeks after initiation of the treatments depending on the day of referral.
The participants were followed up by the psychiatrist during the study. The psychiatrist examined them for side effects, depression symptoms, and the risk of suicide and recorded the relevant data. If the risk of suicide was diagnosed at any stage of treatment, they were immediately referred to the psychiatrist for treatment. The data were gathered through interview, the questionnaires of demographic characteristics, side effects and the Hamilton Depression Rating Scale. For ethical considerations, a form enlisting the side effects was provided to all the participants to record potential side effects.
Concurrent validity yielded moderate to high correlation coefficients, 0.55-0.96 and r=72 mdn, with clinical rating of psychiatric patients. The corresponding correlation coefficient was obtained 0.73 with the Hamilton Depression Rating Scale [31] .
The scores 17-24 were considered mild depression, 25-30 moderate depression, and the total scores above 31 severe depression [32, 33] . The data were analysed by descriptive statistics, chi-square, and t-test was used. Data analysis was conducted by SPSS version 17.0.
RESuLtS
The data on the age, gender, education level, and place of residence were compared among the groups. The mean (standard deviation) age of the patients was 36.7±2.09, 38.2±2.32 and 34.9±2.16 in control, case and placebo respectively. There was no significant difference among three groups (p=0.55). The chi-square results 22 (55) 20 (50) 
dISCuSSIOn
This study was conducted to determine the effects of venlafaxine and L. officinalis in treating people with depression at three points of time.
In this study, the depression indices in Venlafaxine Group obviously decreased (from 1.04±0.01 at the baseline to 0.71±0.01 in the six weeks after treatment) while in L. officinalis and placebo groups, no significant difference in decreased depression scores at different intervals was seen (p>0.05).
Also, a double-blind clinical trial to investigate the effects of L. officinalis tincture and imipramine in treating mild to moderate depression, found that the effect of the L. officinalis effect was lesser than the imipramine effect. However, combined imipramine and L. officinalis tincture was more effective than the imipramine alone [32] . Relevantly, another study using the Hamilton Depression Rating Scale to measure the depression severity, demonstrated that the mean depression indices of the case group, administered with citalopram and L. officinalis, declined more notably than the control group, administered with citalopram alone, after eight weeks [33] . A study reported that L. officinalis cream could relieve anxiety, stress, and depression of pregnant women [34] . Depression may be associated with other mental illnesses and no consideration of such classification was a limitation of the present study. Because depression is a chronic disease and the effect duration of different drugs may vary, future studies are recommended to adopt a longer duration for administration of the drugs under study. Moreover, to obtain higher quality findings, future studies should examine the efficacy of a single drug or multiple drugs in a pilot study and then assign the patients into treatments of interest in main study. Toxicity is an important issue about the medicinal plants.
LIMItAtIOn
Other mental illnesses concomitant with depression was one of the limitations of this study.
COnCLuSIOn
Adding L. officinalis or a placebo is equally effective in decreasing mean depression score. In contrast, in Venlafaxine Group the decrease in mean depression score was more marked compared to the other groups.
